Major Progress for a Less Common Cancer
- 1 January 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (1) , 6-8
- https://doi.org/10.1200/jco.2005.03.8836
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2006
- Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials GroupJournal of Clinical Oncology, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancersSeminars in Oncology, 2004
- Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometriumGynecologic Oncology, 2004
- Outcome of High-Risk Stage IC, Grade 3, Compared With Stage I Endometrial Carcinoma Patients: The Postoperative Radiation Therapy in Endometrial Carcinoma TrialJournal of Clinical Oncology, 2004
- Carcinoma of the corpus uteriInternational Journal of Gynecology & Obstetrics, 2003
- Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomised multicentre studyEuropean Journal Of Cancer, 1993
- Increased uterine prostaglandin E receptors in menorrhagic womenBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Progestin Therapy of Endometrial, Breast and Ovarian CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1984